FDA recall, , Moderate risk
Broadway Joe's Pain Cream
Broadway Joe's Pain Cream may be contaminated due to raw material issues.
What happened
Lexia LLC of Franklin, Tennessee is recalling Broadway Joe's Pain Cream products due to potential contamination of raw material used to manufacture the product. The recall, which began August 21, 2026, covers the 2 oz-jar and 4 oz-jar versions of the cream. The FDA added the recall to its Enforcement Report on September 1, 2026, and classified it on September 2, 2026. The products were distributed in Colorado.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
2 products
Match the lot code and NDC or UPC listed under your product.
A UPC is the number printed under a barcode. An NDC (National Drug Code) is usually printed on the drug's label.
Broadway Joe's Pain Cream, (Histamine Dihydrochloride 0.025%)
- Strength
- 1500 mg
- NDC or UPC
- NDC 83088-8120-5
- UPC 8 50041 64003 7
- Lot code
- T1110
Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate
- Strength
- 3000 mg
- NDC or UPC
- NDC 83088-8120-6
- UPC 8 50041 64004 4
- Lot code
- T1110
Recall details
- Company began the recall
- Sold in
- Company
- Lexia LLCFranklin, Tennessee
- Hazard
- Contamination
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99751
- Recall numbers
- D-0828-2026 to D-0829-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Classified by FDA · Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated



